6
4

American Cures Act

5/15/2026, 6:34 PM

Summary of Bill S 4494

The bill titled "A bill to prioritize funding for an expanded and sustained national investment in biomedical research," designated as S. 4494 in the 119th Congress, was introduced on May 12, 2026. The purpose of the bill is to emphasize funding for an enhanced and continual national commitment to biomedical research.

Congressional Summary of S 4494

American Cures Act

This bill permanently funds several federal agencies and programs that perform biomedical research.

The bill provides specified funding for

  • the National Institutes of Health,
  • the Centers for Disease Control and Prevention,
  • the Department of Defense health program, and
  • the Department of Veterans Affairs medical and prosthetics research program.

The bill exempts the funding from sequestration, which is a process of automatic, usually across-the-board spending reductions under which budgetary resources are permanently cancelled to enforce specific budget policy goals.

It also exempts the budgetary effects of the funding from the Statutory Pay-As-You-Go (PAYGO) Act of 2010 and the Senate PAYGO rule.

Current Status of Bill S 4494

Bill S 4494 is currently in the status of Bill Introduced since May 12, 2026. Bill S 4494 was introduced during Congress 119 and was introduced to the Senate on May 12, 2026.  Bill S 4494's most recent activity was Read twice and referred to the Committee on Appropriations. (text: CR S2239) as of May 12, 2026

Bipartisan Support of Bill S 4494

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
3
Democrat Cosponsors
3
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 4494

Primary Policy Focus

Health

Alternate Title(s) of Bill S 4494

A bill to prioritize funding for an expanded and sustained national investment in biomedical research.
A bill to prioritize funding for an expanded and sustained national investment in biomedical research.

Comments